Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Which Treatment Is Right for Me or My Child?
source: Children's National Hospital
year: 2020
summary/abstract:Overview of Presentation:
• Background: Timeline of Therapies in SCD
• Background: Complications in Sickle Cell Disease
• Review of current disease modifying therapies and clinical trials
• Review of new mechanisms of action for new disease modifying therapies
• Considerations and Clinical Scenarios for therapies in SCD
• Review current FDA approved treatments and Curative therapies
Future for new Therapies Are Bright for SCD!
• There are over 20 new therapeutic products under investigation for SCD
• These include Bone Marrow Transplant and Gene Therapies
read more
Related Content
-
Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell DiseaseBackground: Sickle cell disease is char...
-
Hydroxyurea for children with sickle cell anemia in Sub-Saharan AfricaBackground: Hydroxyurea is an effective...
-
Sarah Reeves, PhD, MPHDr. Reeves’ research is focused on imp...
-
Sickle Cell Support GroupUI Health's Sickle Cell Support Group me...
-
2022 PCORI Annual MeetingThe PCORI Annual Meeting brings together...
-
Children’s National Health SystemSickle cell disease affects many familie...
-
Annual Sickle Cell Disease and Thalassaemia Conference (ASCAT) 2022The Annual Scientific Conference on Sick...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.